Pay in 4 interest-free payments of $5.79 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
[129-131] A phase I human trial found 6 g/day NAC completely protected against hematuria, which is a dose-limiting side effect of ifosfamide (an analogue of cyclophosphamide)
Your IP: 45.3.39.1
Here are some general guidelines: Mild Deficiency: For those with a mild deficiency, a typical dosage might be 1,000 micrograms (mcg) once a week for several weeks
A., Andriushenko, A
Hepatoprotective effect of matrine salvianolic acid B salt on carbon tetrachloride-induced hepatic fibrosis
These positive results in IIb trial were more pronounced among patients with SLEDAI-2K 6 at baseline, showing that 61.9% achieved SRI response at week 12 vs
US$ 22.88
US$ 23.10
US$ 26.03
US$ 21.78
US$ 29.50
